Speaker illustration

Doctor Matteo Beltrami

Careggi, Florence (Italy)

I was born in Siena and I obtained my medical degree at University of Siena. I completed my 5-years training with fellowships in cardiology at the University of Florence. During the postgraduate program I worked as a research fellow at the Cardiomyopathy Unit, University of Florence focusing my studies in Cardiomyopathies and Heart Failure. During my career i spend a training period in Bristol Heart Institute and in CNR, University of Pisa, improving my skills in Heart Failure and Cardiac Magnetic Resonance. I have completed my PhD program on genetics, oncology and clinical medicine at the University of Siena (20/12/2020). I’m working full time as cardiologist at Careggi University Hospital in Florence with duties in Heart Failure, device therapy and Cardiomyopathies outpatient program. I’m working in collaboration with the University of Florence with Prof Iacopo Olivotto at the Cardiomyopathy Unit (Tuscany referral Center for Cardiomyopathies).

The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer?

Event: ESC Congress 2024

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Devices in heart failure: new findings

Thumbnail

Relation of QRS duration to response to cardiac resynchronization therapy in patients with left bundle branch block

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Thumbnail

Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Thumbnail

Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Thumbnail

Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Thumbnail